Federal Bank Allots Equity Shares Under Employee Stock Option Schemes on May 09, 2026

Federal Bank has allotted equity shares to option grantees under its Employee Stock Option Schemes — ESOS 2010 and ESOS 2017 — on May 09, 2026. The allotments were made pursuant to the exercise of stock options by eligible employees, following approval by the bank's Nomination, Remuneration, Ethics and Compensation Committee and receipt of payment from the allottees.

Allotment Details Under ESOS 2010 and ESOS 2017

The bank disclosed the allotment details via a regulatory filing dated May 10, 2026, signed by Company Secretary Samir P Rajdev. The following table summarises the equity shares allotted under each scheme:

Parameter: ESOS 2010 ESOS 2017 Allotment Date: May 09, 2026 May 09, 2026 Number of Shares Allotted: 6,165 2,23,722 Face Value per Share: Rs. 2/- Rs. 2/- Scheme: ESOS 2010 ESOS 2017

Under ESOS 2010, a total of 6,165 (Six Thousand One Hundred and Sixty-Five) equity shares with a face value of Rs. 2/- each were allotted to option grantees. Under ESOS 2017, 2,23,722 (Two Lakh Twenty-Three Thousand Seven Hundred and Twenty-Two) equity shares with a face value of Rs. 2/- each were allotted.

Regulatory Disclosure

The allotment was communicated to both the National Stock Exchange of India Limited and BSE Limited in accordance with Regulation 30 requirements. The filing, referenced as SEC/ESOS/51/2026-27, was submitted by the Secretarial Department of Federal Bank and confirmed that all allotments were made after receipt of payment from the respective allottees.

Federal Bank has allotted equity shares to eligible option grantees on two separate occasions following the exercise of stock options under its Employee Stock Option Schemes. The allotments, approved by the Nomination, Remuneration, Ethics and Compensation Committee, were made after receipt of payment from the respective allottees.

Allotment Details Under ESOS Schemes

The bank completed allotments under two distinct ESOS schemes across two allotment dates. The following table summarises the key details of each allotment:

Parameter: ESOS 2010 Scheme ESOS 2017 Scheme Shares Allotted (May 03, 2026): 21,875 3,74,244 Shares Allotted (May 09, 2026): 6,165 2,23,722 Face Value Per Share: Rs. 2/- Rs. 2/- Allottees: Option Grantees Option Grantees

Regulatory Disclosure

Both allotments were communicated to the National Stock Exchange of India Limited and BSE Limited under Regulation 30, in accordance with applicable disclosure requirements. The first intimation was issued bearing reference SEC/ESOS/43/2026-27, and the subsequent intimation bearing reference SEC/ESOS/51/2026-27, both signed by Company Secretary Samir P Rajdev on behalf of Federal Bank's Secretarial Department.

Key Highlights

ESOS 2010 (May 03, 2026): 21,875 equity shares allotted with a face value of Rs. 2/- each

ESOS 2017 (May 03, 2026): 3,74,244 equity shares allotted with a face value of Rs. 2/- each

ESOS 2010 (May 09, 2026): 6,165 equity shares allotted with a face value of Rs. 2/- each

ESOS 2017 (May 09, 2026): 2,23,722 equity shares allotted with a face value of Rs. 2/- each

All allotments made following payment by the respective option grantees

Approved by the Nomination, Remuneration, Ethics and Compensation Committee

Disclosures filed with both NSE and BSE

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.